Study of the R3 Vascular Drug-Eluting Bioresorbable Scaffold in Treating Below the Knee Arterial Disease
Study of the R3 Vascular Drug-Eluting Bioresorbable Scaffold in Treating Below the Knee Arterial Disease
Recruiting · NCT04912323 · Registry updated 2024-04-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of the R3 Vascular Drug-Eluting Bioresorbable Scaffold in Treating Below the Knee Arterial Disease | Arterial Occlusive Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, intermittent vascular claudication, peripheral arterial disease, peripheral vascular disease, vascular disorder | Recruiting | Not applicable | 2024-04-09 | NCT04912323 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cardiovascular Research Foundation, New York | 16 |
| Massachusetts General Physicians Organization / Vascore | 1 |
| R3 Vascular Inc. | 3 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CRCHUM Université Montreal | Montreal | Canada | 1 |
| Hopital Saint-Francois d'Assise | Québec | Canada | 1 |
| IRCCS Multimedica | Milan | Italy | 2 |
| Maria Cecilia Hospital | Cotignola | Italy | 4 |
| Medical University Graz | Graz | Austria | 11 |
| San Donato Hospital | Arezzo | Italy | 1 |
| Toronto General Hospital | Toronto | Canada | 9 |